SARALASIN [484387]
SARALASIN
| SMILES | CNCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C |
| InChIKey | PFGWGEPQIUAZME-NXSMLHPHSA-N |
| Sequence | None |
| HELM | PEPTIDE1{[Sar].R.V.Y.V.H.P.A}$$$$ |
Chemical Properties
| Hydrogen bond acceptors | 12 |
| Hydrogen bond donors | 13 |
| Rotatable bonds | 25 |
| Log P | -2.301 |
| Molecular weight (Da) | 911.5 |
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
SARALASIN
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | Yes |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0